Lingmin Yuan
- Molecular Biology
- Oncology
- Pharmacology top 10%
- Pediatrics, Perinatology and Child Health
- Epidemiology
- Topics
- Ubiquitin and proteasome pathways (7 papers)Glycosylation and Glycoproteins Research (5 papers)Pharmacogenetics and Drug Metabolism (5 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Lingmin Yuan
17 papers receiving 448 citations
Peers
Comparison fields: 5 of 83
- Molecular Biology 319
- Oncology 178
- Pharmacology 70
- Pediatrics, Perinatology and Child Health 39
- Epidemiology 36
Countries citing papers authored by Lingmin Yuan
This map shows the geographic impact of Lingmin Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingmin Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingmin Yuan more than expected).
Fields of papers citing papers by Lingmin Yuan
This network shows the impact of papers produced by Lingmin Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingmin Yuan. The network helps show where Lingmin Yuan may publish in the future.
Co-authorship network of co-authors of Lingmin Yuan
This figure shows the co-authorship network connecting the top 25 collaborators of Lingmin Yuan. A scholar is included among the top collaborators of Lingmin Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingmin Yuan. Lingmin Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 9 | |
| 6 | 3 | |
| 7 | 22 | |
| 8 | 47 | |
| 9 | 48 | |
| 10 | 51 | |
| 11 | 22 | |
| 12 | 40 | |
| 13 | 24 | |
| 14 | 13 | |
| 15 | 16 | |
| 16 | 81 | |
| 17 | 23 | |
| 18 | 40 | |
| 19 | 9 | |
| 20 | [Screening mutations in phenylketonuria by means of nonradioactive reverse dot blot hybridization]. | 3 |
About Lingmin Yuan
Lingmin Yuan is a scholar working on Pharmacology, Clinical Biochemistry and Virology, having authored 20 papers that have together received 453 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (7 papers), Glycosylation and Glycoproteins Research (5 papers) and Pharmacogenetics and Drug Metabolism (5 papers). The work is most often cited by research in Pharmacology (70 citations), Oncology (178 citations) and Molecular Biology (319 citations). Lingmin Yuan has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Shaun K. Olsen, Zongyang Lv, Su Zeng, Katelyn Williams, Haina Wang, Lushan Yu, Yanqing Liu, Yuan Chen, Yongsheng Xiao and Qinqin Yu. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.